The relevant Memorandum of Understanding was signed on September 19 at the 9th Session of the High-Level Russia-Singapore Inter-Governmental Commission in Singapore.
“Both parties confirmed their interest in joint development of a health center which is expected to include radionuclide diagnostics and therapy departments, an electron beam therapy department, and a cyclotron and radiochemical unit,” says the Rosatom statement.
In April, the Singapore-based AAMG announced its plans to set up the Tunku Laksamana Cancer Center, an advanced cancer treatment center in Malaysia’s state of Johor. The project has received strong support from His Majesty Sultan Ibrahim Ibni Almarhum Sultan Iskandar, the Sultan of Johor.
The Memorandum was signed by Dato’ Dr. Tan Kai Chah, Executive Chairman of AAMG, and Egor Simonov, Director of Rosatom South East Asia, acting on behalf of Rusatom Healthcare.
“Nuclear medicine for diagnosing and treating cancer sufferers has become increasingly popular in Southeast Asia in recent years. The proposed nuclear medicine center, which can serve patients from Malaysia as well as the neighboring Singapore, can position Johor as a leading medical destination with the best oncological care in the region,” Dato’ Dr. Tan Tan Kai Chah said.
“Rusatom Healthcare’s expertise in nuclear medical technologies will ensure the center offers state-of-the-art healthcare services in cancer treatment, research and education,” Egor Simonov assured.
For reference:
The Singapore-based Asian American Medical Group was established in 1994 and has been listed on the Australian Securities Exchange since September 2009. The Group’s operations include the Asian American Liver Centre Pte Ltd (AALC) and the Asian American Radiation Oncology Pte Ltd (AARO).
Rusatom Healthcare, a 100% Rosatom subsidiary, provides a full range of services in nuclear medicine, from facility construction and operation to supplies of isotopes worldwide.
